0001188112-13-000551.txt : 20130304 0001188112-13-000551.hdr.sgml : 20130304 20130304160553 ACCESSION NUMBER: 0001188112-13-000551 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130301 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20130304 DATE AS OF CHANGE: 20130304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC CENTRAL INDEX KEY: 0000744452 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 592262718 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 002-90539 FILM NUMBER: 13661647 BUSINESS ADDRESS: STREET 1: 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: STONY BROOK STATE: NY ZIP: 11790 BUSINESS PHONE: 631 444 6861 MAIL ADDRESS: STREET 1: 25 HEALTH SCIENCES DRIVE STREET 2: SUITE 113 CITY: STONY BROOK STATE: NY ZIP: 11790 FORMER COMPANY: FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC DATE OF NAME CHANGE: 20010504 FORMER COMPANY: FORMER CONFORMED NAME: DCC ACQUISITION CORP DATE OF NAME CHANGE: 19990211 FORMER COMPANY: FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/ DATE OF NAME CHANGE: 19980306 8-K 1 t75753_8k.htm FORM 8-K t75753_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
 
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
 
Date of report (Date of earliest event reported): March 1, 2013
Applied DNA Sciences, Inc.
 
(Exact Name of Registrant as Specified in Charter)
 
Delaware
(State or Other Jurisdiction
of Incorporation)
002-90539
(Commission File Number)
59-2262718
(IRS Employer
Identification No.)

 
 
25 Health Sciences Drive, Suite 215
Stony Brook, New York 11790
(Address of Principal Executive Offices) (Zip Code)
 
631-444-8090
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
 
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 40.14d - (b))
 
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e - (c))
 
 
 
 
 
 
Item 5.07.  Submission of Matters to a Vote of Security Holders.
 
On March 1, 2013, Applied DNA Sciences, Inc. (the “Company”) held its Annual Meeting of Stockholders.  The following proposals were voted on and approved by the Company’s stockholders at the Annual Meeting with the stockholders having voted as set forth below:
 
Proposal 1 - to elect our board of directors, consisting of James A. Hayward, John Bitzer, III, Karol Gray, Charles Ryan, Yacov Shamash, and Sanford R. Simon, each for a one-year term or until their successors are duly elected and qualified:

 
Directors
  
For
  
Withheld
 
James A. Hayward
  
348,700,367
  
633,491
 
John Bitzer, III
  
348,559,436
  
774,422
 
Karol Gray
  
348,656,413
  
677,445
 
Charles Ryan
  
348,607,531
  
726,327
 
Yacov Shamash
  
348,508,645
  
825,213
 
Sanford R. Simon
  
348,553,032
  
780,826

Broker Non-Votes:  184,888,047
 
Proposal 2 - to approve an advisory vote on executive compensation:

For
  
Against
  
Abstain
346,675,163
  
1,836,481
  
822,214

Broker Non-Votes:  184,888,047
 
 
 
 
 
 
Proposal 3 - to hold an advisory vote on the frequency of future executive compensation advisory votes.
 
1 Year
  
2 Years
  
3 Years
  
Abstain
9,284,034
  
43,862,167
  
295,032,754
  
1,154,903

Broker Non-Votes:  184,888,047

The Board of Directors of the Company, taking into account the foregoing advisory vote of the stockholders of the Company, has determined that the Company will hold an advisory vote on executive compensation every three years.

Proposal 4- to ratify the appointment of RBSM, LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2013.
 
For
  
Against
  
Abstain
          525,894,273                    7,760,058                   567,574        

 
Broker Non-Votes:  0
 
 
 
 
 
 

SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Applied DNA Sciences, Inc.
  
 
(Registrant)
  
     
     
  By: /s/ James A. Hayward  
    James A. Hayward  
   
Chief Executive Officer
  
       
       
       
       
Date:  March 4, 2013